Edwards Lifesciences CorporationEWNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+49.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+49.1%/yr
vs -15.4%/yr prior
Acceleration
+64.5pp
Accelerating
Percentile
P86
Within normal range
vs 3Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 16.54% |
| 2024 | 13.06% |
| 2023 | 0.95% |
| 2022 | 4.99% |
| 2021 | 21.33% |
| 2020 | -0.93% |
| 2019 | 14.35% |
| 2018 | 9.75% |
| 2017 | 9.94% |
| 2016 | 5.86% |